Suppr超能文献

钙调蛋白与细胞骨架功能的调节

Caldesmon and the regulation of cytoskeletal functions.

作者信息

Wang C L Albert

机构信息

Boston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02472, USA.

出版信息

Adv Exp Med Biol. 2008;644:250-72. doi: 10.1007/978-0-387-85766-4_19.

Abstract

Caldesmon (CaD) is an extraordinary actin-binding protein, because in addition to actin, it also bindsmyosin, calmodulin and tropomyosin. As a component of the smoothmuscle and nonmuscle contractile apparatus CaD inhibits the actomyosin ATPase activity and its inhibitory action is modulated by both Ca2+ and phosphorylation. The multiplicity of binding partners and diverse biochemical properties suggest CaD is a potent and versatile regulatory protein both in contractility and cell motility. However, after decades ofinvestigation in numerous laboratories, hard evidence is still lacking to unequivocally identify its in vivo functions, although indirect evidence is mounting to support an important role in connection with the actin cytoskeleton. This chapter reviews the highlights of the past findings and summarizes the current views on this protein, with emphasis of its interaction with tropomyosin.

摘要

钙调蛋白(CaD)是一种特殊的肌动蛋白结合蛋白,因为除了肌动蛋白外,它还能结合肌球蛋白、钙调蛋白和原肌球蛋白。作为平滑肌和非肌肉收缩装置的组成部分,CaD抑制肌动球蛋白ATP酶活性,其抑制作用受Ca2+和磷酸化的调节。结合伙伴的多样性和多样的生化特性表明,CaD在收缩性和细胞运动性方面都是一种强大且多功能的调节蛋白。然而,经过众多实验室数十年的研究,尽管越来越多的间接证据支持其在肌动蛋白细胞骨架方面发挥重要作用,但仍缺乏确凿证据来明确确定其体内功能。本章回顾了过去研究结果的要点,并总结了关于该蛋白的当前观点,重点是其与原肌球蛋白的相互作用。

相似文献

1
Caldesmon and the regulation of cytoskeletal functions.
Adv Exp Med Biol. 2008;644:250-72. doi: 10.1007/978-0-387-85766-4_19.
2
The effects of phosphorylation of smooth-muscle caldesmon.
Biochem J. 1987 Jun 1;244(2):417-25. doi: 10.1042/bj2440417.
3
Effect of caldesmon on the position and myosin-induced movement of smooth muscle tropomyosin bound to actin.
J Biol Chem. 2005 Feb 11;280(6):4135-43. doi: 10.1074/jbc.M410375200. Epub 2004 Oct 24.
4
Nonmuscle caldesmon: its distribution and involvement in various cellular processes. Review article.
Protoplasma. 2004 Oct;224(1-2):1-13. doi: 10.1007/s00709-004-0057-3.
5
Chapter 1: roles of caldesmon in cell motility and actin cytoskeleton remodeling.
Int Rev Cell Mol Biol. 2009;274:1-68. doi: 10.1016/S1937-6448(08)02001-7.
10
Caldesmon: a calmodulin-binding actin-regulatory protein.
Cell Calcium. 1986 Dec;7(5-6):309-27. doi: 10.1016/0143-4160(86)90035-7.

引用本文的文献

2
3
Caldesmon: Biochemical and Clinical Implications in Cancer.
Front Cell Dev Biol. 2021 Feb 18;9:634759. doi: 10.3389/fcell.2021.634759. eCollection 2021.
4
L-caldesmon alters cell spreading and adhesion force in RANKL-induced osteoclasts.
J Biomed Sci. 2019 Jan 24;26(1):12. doi: 10.1186/s12929-019-0505-1.
5
Effect of l-caldesmon on osteoclastogenesis in RANKL-induced RAW264.7 cells.
J Cell Physiol. 2018 Sep;233(9):6888-6901. doi: 10.1002/jcp.26452. Epub 2018 Mar 25.
7
YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro.
BMC Cancer. 2017 Mar 16;17(1):201. doi: 10.1186/s12885-017-3187-7.
8
Forkhead box O member FOXO1 regulates the majority of follicle-stimulating hormone responsive genes in ovarian granulosa cells.
Mol Cell Endocrinol. 2016 Oct 15;434:116-26. doi: 10.1016/j.mce.2016.06.020. Epub 2016 Jun 17.
9
Regulation of mitogen-activated protein kinase by protein kinase C and mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle.
Am J Physiol Cell Physiol. 2016 Jun 1;310(11):C921-30. doi: 10.1152/ajpcell.00311.2015. Epub 2016 Apr 6.

本文引用的文献

1
Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation.
FEBS Lett. 2007 Aug 7;581(20):3777-82. doi: 10.1016/j.febslet.2007.06.073. Epub 2007 Jul 5.
3
Erk1/2 MAPK and caldesmon differentially regulate podosome dynamics in A7r5 vascular smooth muscle cells.
Exp Cell Res. 2007 Mar 10;313(5):849-66. doi: 10.1016/j.yexcr.2006.12.005. Epub 2006 Dec 21.
4
Changes in the balance between caldesmon regulated by p21-activated kinases and the Arp2/3 complex govern podosome formation.
J Biol Chem. 2007 Mar 16;282(11):8454-63. doi: 10.1074/jbc.M609983200. Epub 2007 Jan 15.
5
Solitary fibrous tumor of the orbit: morphological, cytogenetic and molecular features.
Neuropathology. 2006 Dec;26(6):557-63. doi: 10.1111/j.1440-1789.2006.00726.x.
6
Direct interaction between caldesmon and cortactin.
Arch Biochem Biophys. 2006 Dec 15;456(2):175-82. doi: 10.1016/j.abb.2006.07.018. Epub 2006 Aug 23.
7
l-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty.
Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2231-7. doi: 10.1161/01.ATV.0000239441.29687.97. Epub 2006 Aug 3.
8
Tropomyosin isoforms localize to distinct microfilament populations in osteoclasts.
Bone. 2006 Oct;39(4):694-705. doi: 10.1016/j.bone.2006.04.031. Epub 2006 Jun 12.
9
Caldesmon effects on the actin cytoskeleton and cell adhesion in cultured HTM cells.
Exp Eye Res. 2006 Jun;82(6):945-58. doi: 10.1016/j.exer.2006.01.006.
10
Phosphorylated HSP27 modulates the association of phosphorylated caldesmon with tropomyosin in colonic smooth muscle.
Am J Physiol Gastrointest Liver Physiol. 2006 Oct;291(4):G630-9. doi: 10.1152/ajpgi.00350.2005. Epub 2006 Apr 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验